Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

Abroad (travel likely)RecruitingPHASE2

Conditions

Group 3 Pulmonary Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Bassem Elmankabadi, MD

    Study Director

    Foresee Pharmaceuticals